Clinical variable-based cluster analysis identifies novel subgroups with a distinct genetic signature, lipidomic pattern and cardio-renal risks in Asian patients with recent-onset type 2 diabetes
Authors:
Open Access
- 28 June 2022
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 65 (12) , 2146-2156
Abstract
Aims/hypothesis: We sought to subtype South East Asian patients with type 2 diabetes by de novo cluster analysis on clinical variables, and to determine whether the novel subgroups carry distinct genetic and lipidomic features as well as differential cardio-renal risks. Methods: Analysis by k-means algorithm was performed in 687 participants with recent-onset diabetes in Singapore. Genetic risk for beta cell dysfunction was assessed by polygenic risk score. We used a discovery–validation approach for the lipidomics study. Risks for cardio-renal complications were studied by survival analysis. Results: Cluster analysis identified three novel diabetic subgroups, i.e. mild obesity-related diabetes (MOD, 45%), mild age-related diabetes with insulin insufficiency (MARD-II, 36%) and severe insulin-resistant diabetes with relative insulin insufficiency (SIRD-RII, 19%). Compared with the MOD subgroup, MARD-II had a higher polygenic risk score for beta cell dysfunction. The SIRD-RII subgroup had higher levels of sphingolipids (ceramides and sphingomyelins) and glycerophospholipids (phosphatidylethanolamine and phosphatidylcholine), whereas the MARD-II subgroup had lower levels of sphingolipids and glycerophospholipids but higher levels of lysophosphatidylcholines. Over a median of 7.3 years follow-up, the SIRD-RII subgroup had the highest risks for incident heart failure and progressive kidney disease, while the MARD-II subgroup had moderately elevated risk for kidney disease progression. Conclusions/interpretation: Cluster analysis on clinical variables identified novel subgroups with distinct genetic, lipidomic signatures and varying cardio-renal risks in South East Asian participants with type 2 diabetes. Our study suggests that this easily actionable approach may be adapted in other ethnic populations to stratify the heterogeneous type 2 diabetes population for precision medicine. GraphicalKeywords
Funding Information
- Khoo Teck Puat hospital STAR Grant (18203, 20201)
- Singapore National Medical Research Council (CSA-INV/0020/2017, CS-IRG MOH-000066, OFLCG/001/20)
This publication has 40 references indexed in Scilit:
- Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variablesThe Lancet Diabetes & Endocrinology, 2018
- Epidemiology of diabetes and diabetic complications in ChinaDiabetologia, 2018
- Painting a new picture of personalised medicine for diabetesDiabetologia, 2017
- Plasma Lipidomic Profiles Improve on Traditional Risk Factors for the Prediction of Cardiovascular Events in Type 2 Diabetes MellitusCirculation, 2016
- Genetic variants in the receptor for advanced glycation end products ( RAGE ) gene were associated with circulating soluble RAGE level but not with renal function among Asians with type 2 diabetes: a genome-wide association studyNephrology Dialysis Transplantation, 2016
- Elevation of a Novel Angiogenic Factor, Leucine-Rich-α2-Glycoprotein (LRG1), Is Associated With Arterial Stiffness, Endothelial Dysfunction, and Peripheral Arterial Disease in Patients With Type 2 DiabetesThe Journal of Clinical Endocrinology & Metabolism, 2015
- Diabetes and its comorbidities—where East meets WestNature Reviews Endocrinology, 2013
- A New Equation to Estimate Glomerular Filtration RateAnnals of Internal Medicine, 2009
- Cluster-wise assessment of cluster stabilityComputational Statistics & Data Analysis, 2007
- Use of Metabolic Markers To Identify Overweight Individuals Who Are Insulin ResistantAnnals of Internal Medicine, 2003